Literature DB >> 10780922

Familial juvenile hyperuricemic nephropathy: localization of the gene on chromosome 16p11.2-and evidence for genetic heterogeneity.

B Stibůrková1, J Majewski, I Sebesta, W Zhang, J Ott, S Kmoch.   

Abstract

Familial juvenile hyperuricemic nephropathy (FJHN), is an autosomal dominant renal disease characterized by juvenile onset of hyperuricemia, gouty arthritis, and progressive renal failure at an early age. Using a genomewide linkage analysis in three Czech affected families, we have identified, on chromosome 16p11.2, a locus for FJHN and have found evidence for genetic heterogeneity and reduced penetrance of the disease. The maximum two-point LOD score calculated with allowance for heterogeneity (HLOD) was 4.70, obtained at recombination fraction 0, with marker D16S3036; multipoint linkage analysis yielded a maximum HLOD score of 4.76 at the same location. Haplotype analysis defined a 10-cM candidate region between flanking markers D16S501 and D16S3113, exhibiting crossover events with the disease locus. The candidate interval contains several genes expressed in the kidney, two of which-uromodulin and NADP-regulated thyroid-hormone-binding protein-represent promising candidates for further analysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780922      PMCID: PMC1378048          DOI: 10.1086/302936

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis.

Authors:  J R O'Connell; D E Weeks
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

2.  Purification, molecular cloning, and functional expression of the human nicodinamide-adenine dinucleotide phosphate-regulated thyroid hormone-binding protein.

Authors:  M P Vié; C Evrard; J Osty; A Breton-Gilet; P Blanchet; M Pomérance; P Rouget; J Francon; J P Blondeau
Journal:  Mol Endocrinol       Date:  1997-10

3.  Medullary cystic kidney disease with hyperuricemia and gout in a large Cypriot family: no allelism with nephronophthisis type 1.

Authors:  C Stavrou; A Pierides; I Zouvani; K Kyriacou; C Antignac; P Neophytou; K Christodoulou; C C Deltas
Journal:  Am J Med Genet       Date:  1998-05-01

4.  High affinity thyroid hormone-binding protein in human kidney: kinetic characterization and identification by photoaffinity labeling.

Authors:  M P Vié; P Blanchet; M Samson; J Francon; J P Blondeau
Journal:  Endocrinology       Date:  1996-11       Impact factor: 4.736

5.  Faster sequential genetic linkage computations.

Authors:  R W Cottingham; R M Idury; A A Schäffer
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

6.  Reversible renal insufficiency, hyperuricemia and gouty arthritis in a case of hypothyroidism.

Authors:  A Mooraki; B Bastani
Journal:  Clin Nephrol       Date:  1998-01       Impact factor: 0.975

7.  [Familial juvenile gouty nephropathy].

Authors:  K Pavelka; I Sebesta; J Blovská; J Malý; M Chadimová
Journal:  Cas Lek Cesk       Date:  1996-10-23

8.  Familial renal disease or familial juvenile hyperuricaemic nephropathy?

Authors:  M B McBride; H A Simmonds; F Moro
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

9.  Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children.

Authors:  M B McBride; S Rigden; G B Haycock; N Dalton; W Van't Hoff; L Rees; G V Raman; F Moro; C S Ogg; J S Cameron; H A Simmonds
Journal:  Pediatr Nephrol       Date:  1998-06       Impact factor: 3.714

10.  Apoptosis of tubular epithelial cells in familial juvenile gouty nephropathy.

Authors:  K Lhotta; J Gruber; R Sgonc; F Fend; P König
Journal:  Nephron       Date:  1998       Impact factor: 2.847

View more
  6 in total

Review 1.  Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.

Authors:  Lesley A Graham; Anna F Dominiczak; Nicholas R Ferreri
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

2.  Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy.

Authors:  T C Hart; M C Gorry; P S Hart; A S Woodard; Z Shihabi; J Sandhu; B Shirts; L Xu; H Zhu; M M Barmada; A J Bleyer
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

3.  16p11.2 transcription factor MAZ is a dosage-sensitive regulator of genitourinary development.

Authors:  Meade Haller; Jason Au; Marisol O'Neill; Dolores J Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

4.  A novel heterozygous missense mutation in the UMOD gene responsible for Familial Juvenile Hyperuricemic Nephropathy.

Authors:  Joaquim Calado; Augusta Gaspar; Carla Clemente; José Rueff
Journal:  BMC Med Genet       Date:  2005-01-27       Impact factor: 2.103

5.  First Report of Familial Juvenile Hyperuricemic Nephropathy (FJHN) in Iran Caused By a Novel De Novo Mutation (E197X) in UMOD.

Authors:  Tahereh Malakoutian; Atefeh Amouzegar; Farzaneh Vali; Mojgan Asgari; Babak Behnam
Journal:  J Mol Genet Med       Date:  2016-05-29

6.  Unilateral hypoplastic kidney - a novel highly penetrant feature of familial juvenile hyperuricaemic nephropathy.

Authors:  Lucy A Plumb; Matko Marlais; Agnieszka Bierzynska; Howard Martin; Kim Brugger; Stephen Abbs; Moin A Saleem
Journal:  BMC Nephrol       Date:  2014-05-09       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.